Entries by Sommer Aweidah

,

Animal hospital readies move to new quarters

This article was originally published in the Eagle Tribune,  June 17, 2019 By Jill Harmacinski Follow staff reporter Jill Harmacinski on Twitter @EagleTribJill. LAWRENCE — A North Andover animal hospital is preparing its long-planned move to its new home on Route 114 in Lawrence to the Route 114 site of the previous Showcase Cinemas. Bulger Veterinary Hospital will move […]

,

Bulger Veterinary Hospital Relocates to New, State-of-The-Art Facility Enhancing its Ability to Care for Pets

Lawrence, Mass. — June 12, 2019  – Bulger Veterinary Hospital will move to its new location at the former Showcase Cinema site in Lawrence, Massachusetts, located at 141 Winthrop Avenue in Lawrence, MA  the last week of June. The move brings the highly recognized 60-plus year-old Bulger Veterinary Hospital 2 miles, from neighboring North Andover to Lawrence, creating an […]

, , ,

LexaGene Places its First Beta Prototype into Massachusetts Veterinary Referral Hospital

Source: LexaGene Holdings Inc BEVERLY, Mass., June 05, 2019 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today that it has placed its first beta prototype into Massachusetts Veterinary Referral Hospital (Mass Vet) in Woburn, MA.  Mass Vet is one of […]

, , ,

New study boasts 90% accuracy when using PARR to diagnose canine lymphoma

Article originally published in NEWStat, an American Animal Hospital Association Publication  Written by Tony McReynolds Who measures the measurements? Who diagnoses the diagnostics? In short, who assays the assays? Veterinarians have been using polymerase chain reaction for antigen receptor rearrangement (PARR), a readily available molecular assay that helps diagnose some kinds of canine lymphoma, for years. […]

, , , , ,

TGEN-Ethos Study Underscores Need for Setting High Standards in Veterinary Cancer Diagnostics

Written by Steve Yozwiak PHOENIX, Ariz. — May 21, 2019 — Ethos Veterinary Health, Ethos Discovery, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced today that they have developed a highly accurate test for the diagnosis of canine lymphoma. In a study published in the Journal of Veterinary Internal […]

, , ,

AAHA, VetBloom to Launch Exclusive AAHA Member Learning Platform

LAKEWOOD, Colorado – April 30, 2019 – In a move that brings a veterinary industry leader in online CE together with the only association to accredit companion animal hospitals in North America, VetBloom and the American Animal Hospital Association (AAHA) are excited to announce the upcoming launch of the AAHA | Learning platform. Provided as an exclusive AAHA […]

,

Metronomic Chemotherapy

Written by Mairin Miller, DVM (Residency-trained in Oncology) Overview Metronomic chemotherapy (MC) is the oral administration of anticancer drugs at low, minimally toxic doses on a frequent or continuous schedule. This is commonly executed using a combination of cyclophosphamide (cytoxan) and piroxicam, however several other protocols have been published, including chlorambucil, etoposide and thalidomide. It is […]

,

Clinical Trial: Novel Pain Management Therapy in Dogs with Severe Elbow Dysplasia

A Funded Clinical Trial to Evaluate a Novel Pain Management Therapy in Dogs with Severe Elbow Dysplasia Trial Specifics This study is designed to evaluate the tolerability, safety and effectiveness of a novel therapy (not yet approved by FDA) to manage pain associated with moderate to severe elbow dysplasia and secondary osteoarthritis in dogs. The […]

, , ,

First-Ever, Nationwide, Multicenter, Prospective Study of Canine Splenic Hemangiosarcoma

Cutting Edge Cancer Research in Veterinary Specialty Practice: Ethos Veterinary Health Completes First-Ever, Nationwide, Multicenter, Prospective Study of Canine Splenic Hemangiosarcoma Woburn, Mass. — Jan. 15, 2019 — Ethos Veterinary Health (Ethos) has completed the patient accrual phase of their new Canine Hemangiosarcoma Molecular Profiling (CHAMP) study. Hemangiosarcoma is one of the most malignant forms of cancer […]